Literature DB >> 32056354

Vps34 derived phosphatidylinositol 3-monophosphate modulates megakaryocyte maturation and proplatelet production through late endosomes/lysosomes.

Ivana Bertović1, Roberta Kurelić1, Ira Milošević2, Markus Bender3, Michael Krauss4, Volker Haucke4, Antonija Jurak Begonja1.   

Abstract

BACKGROUND: Development of platelet precursor cells, megakaryocytes (MKs), implies an increase in their size; formation of the elaborate demarcation membrane system (DMS); and extension of branched cytoplasmic structures, proplatelets, that will release platelets. The membrane source(s) for MK expansion and proplatelet formation have remained elusive.
OBJECTIVE: We hypothesized that traffic of membranes regulated by phosphatidylinositol 3-monophosphate (PI3P) contributes to MK maturation and proplatelet formation.
RESULTS: In immature MKs, PI3P produced by the lipid kinase Vps34 is confined to perinuclear early endosomes (EE), while in mature MKs PI3P shifts to late endosomes and lysosomes (LE/Lys). PI3P partially colocalized with the plasma membrane marker phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2 ) and with LE/Lys in mature MKs, suggests that PI3P-containing LE/Lys membranes contribute to MK expansion and proplatelet formation. Consistently, we found that sequestration of PI3P, specific pharmacological inhibition of Vps34-mediated PI3P production, or depletion of PI3P by PI3-phosphatase (MTM1)-mediated hydrolysis potently blocked proplatelet formation. Moreover, Vps34 inhibition led to the intracellular accumulation of enlarged LE/Lys, and decreased expression of surface LE/Lys markers. Inhibiting Vps34 at earlier MK stages caused aberrant DMS development. Finally, inhibition of LE/Lys membrane fusion by a dominant negative mutant of the small GTPase Rab7 or pharmacological inhibition of PI3P conversion into PI(3,5)P2 led to enlarged LE/Lys, reduced surface levels of LE/Lys markers, and decreased proplatelet formation.
CONCLUSION: Our results suggest that PI3P-positive LE/Lys contribute to the membrane growth and proplatelet formation in MKs by their translocation to the cell periphery and fusion with the plasma membrane.
© 2020 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  lysosomes; megakaryocytes; phosphoinositides; platelets; thrombopoiesis

Mesh:

Substances:

Year:  2020        PMID: 32056354     DOI: 10.1111/jth.14764

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  7 in total

1.  PI3K Isoform Signalling in Platelets.

Authors:  Waltraud C Schrottmaier; Marion Mussbacher; Manuel Salzmann; Julia B Kral-Pointner; Alice Assinger
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

2.  Class III PI3K Biology.

Authors:  Manuella Caux; Gaetan Chicanne; Sonia Severin
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 3.  Phosphoinositide 3-Kinases as Potential Targets for Thrombosis Prevention.

Authors:  Natasha M Setiabakti; Pia Larsson; Justin R Hamilton
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 4.  Recent lessons learned for ex-vivo platelet production.

Authors:  Alice Tang; Avital Mendelson
Journal:  Curr Opin Hematol       Date:  2021-11-01       Impact factor: 3.284

Review 5.  The bone marrow niche from the inside out: how megakaryocytes are shaped by and shape hematopoiesis.

Authors:  Andrew P Stone; Thais F Nascimento; Maria N Barrachina
Journal:  Blood       Date:  2022-01-27       Impact factor: 22.113

Review 6.  Deciphering the Role of the Coagulation Cascade and Autophagy in Cancer-Related Thrombosis and Metastasis.

Authors:  Charlotte Nicole Hill; Maria Paz Hernández-Cáceres; Catalina Asencio; Begoña Torres; Benjamin Solis; Gareth I Owen
Journal:  Front Oncol       Date:  2020-12-07       Impact factor: 6.244

7.  Early Endosomal Vps34-Derived Phosphatidylinositol-3-Phosphate Is Indispensable for the Biogenesis of the Endosomal Recycling Compartment.

Authors:  Marina Marcelić; Hana Mahmutefendić Lučin; Antonija Jurak Begonja; Gordana Blagojević Zagorac; Pero Lučin
Journal:  Cells       Date:  2022-03-11       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.